Out on a high

1 Aug 2005 By Robert Cyran

It may sound defeatist for the pharma group s new boss to flog the company. It isn t. Pharma acquisitions may have a chequered history, but the economic case for the sale of Astra is overwhelming.

This content is for Subscribers only

or
If you need assistance please email breakingviews.clientsupport@thomsonreuters.com
 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)

We need you to verify your email address to continue. Please check your email/junk folder for our verification request.

Click here to resend the verification email.